Metformin and empagliflozin modulate monoamine oxidase-related oxidative stress and improve vascular function in human mammary arteries

• Published in: Molecular and cellular biochemistry 2023-09, Vol.478 (9), p.1939-1947
• Main Authors: Lascu, Ana, Ionică, Loredana N., Buriman, Darius G., Merce, Adrian P., Deaconu, Loredana, Borza, Claudia, Crețu, Octavian M., Sturza, Adrian, Muntean, Danina M., Feier, Horea B.
• Format: Article
• Language: English
• Subjects: Acetylcholine; Amine oxidase (flavin-containing); Angiotensin; Angiotensin II; Antidiabetics; Arteries; Biochemistry; Biomedical and Life Sciences; Body weight; Cancer Research; Cardiology; Cardiovascular disease; Cardiovascular diseases; Cardiovascular system; Confocal microscopy; Coronary artery bypass; Coronary artery disease; Coronary heart disease; Diabetes mellitus; Enzymes; Heart diseases; Heart transplantation; Histochemistry; Immunosuppressive agents; Isoforms; Life Sciences; Medical Biochemistry; Metformin; Monoamine oxidase; Overweight; Oxidation; Oxidative stress; Reactive oxygen species; Spectrophotometry; Stimulation; Veins & arteries
• ISSN: 0300-8177; 1573-4919
• DOI: 10.1007/s11010-022-04633-8

Monoamine oxidases (MAOs), mitochondrial enzymes with two isoforms, A and B, have been recently recognized as significant contributors to oxidative stress in the cardiovascular system. The present study was purported to assess the effect of metformin and empagliflozin on MAO expression, oxidative stress and vascular reactivity in internal mammary arteries harvested from overweight patients with coronary heart disease subjected to bypass grafting. Vascular rings were prepared and acutely incubated (12 h) with high glucose (GLUC, 400 mg/dL) or angiotensin II (AII, 100 nM) and metformin (10 µM) and/or empagliflozin (10 µM) and used for the assessment of MAO expression (qRT-PCR and immune histochemistry), reactive oxygen species (ROS, confocal microscopy and spectrophotometry), and vasomotor function (myograph). Ex vivo stimulation with GLUC or AII increased both MAOs expression, ROS production and impaired relaxation to acetylcholine (ACh) of the vascular rings. All effects were alleviated by incubation with each antidiabetic drug; no cumulative effect was obtained when the drugs were applied together. In conclusion, MAO-A and B are upregulated in mammary arteries after acute stimulation with GLUC and AII. Endothelial dysfunction and oxidative stress were alleviated by either metformin or empagliflozin in both stimulated and non-stimulated vascular samples harvested from overweight cardiac patients.